Aeterna Zentaris to Present at Upcoming Sachs 10th Annual Biotech Europe
Investment Forum on September 29

QUÉBEC CITY, Sept. 22 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will be part of the Oncology Investment panel session at the upcoming Sachs 10th Annual Biotech Europe Investment Forum on Wednesday, September 29, 2010, at 12:00 p.m. (local time), at the Radisson Blu Hotel in Zurich, Switzerland.

That same day, still as part of the Forum, Dr. Engel will also present a corporate overview at 2:15 p.m.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at www.aezsinc.com.

For further information: Investor Relations: Ginette Vallières, Investor Relations Coordinator, [phone] ext. 265, [email protected]; Media Relations: Paul Burroughs, Director of Communications, [phone] ext. 406, [email protected]